Form 4: Atara Biotherapeutics CEO Sells Shares to Cover Tax Obligations

Atara Biotherapeutics CEO, AnhCo Nguyen, sold 1,664 shares of common stock at an average price of $11.198 to cover tax obligations related to vesting restricted stock units.

Summary

• Atara Biotherapeutics CEO, AnhCo Nguyen, sold 1,664 shares of common stock on November 18, 2024.
• The sale was executed at a weighted average price of $11.198 per share.
• The shares were sold to cover tax withholding obligations related to the vesting of previously granted restricted stock units.
• Following the transaction, Nguyen directly owns 77,454 shares of Atara Biotherapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of executive compensation packages, leading to similar tax-related sales.
• The sale price of $11.198 is within the range of recent trading activity for Atara Biotherapeutics stock.

Stakeholder Impact

• The sale of shares by the CEO may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

Atara Biotherapeutics, insider trading, stock sale, executive compensation, tax obligations, restricted stock units, ATRA